104062-70-6

Basic information

• Product Name: Carbamic acid, [(1S)-1-formylpentyl]-, 1,1-dimethylethyl ester
• CAS NO: 104062-70-6
• Molecular Formula: C11H21NO3
• Molecular Weight: 215.293
• Mol File: 104062-70-6.mol
• Article Data: 32

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-1-formylpentyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-1-formylpentyl]-, 1,1-dimethylethyl ester(104062-70-6)
• EPA Substance Registry System: Carbamic acid, [(1S)-1-formylpentyl]-, 1,1-dimethylethyl ester(104062-70-6)

Safety Data

• Hazardous Substances Data: 104062-70-6(Hazardous Substances Data)

Upstream product

• 125342-48-5 2(S)-(tert-Butoxycarbonylamino)hexanoic acid 
• 254438-02-3 [1-(methoxy-methyl-carbamoyl)-pentyl]-carbamic acid tert-butyl ester 
• 80696-29-3 (S)-(+)-2-Amino-1-hexanol 
• 6404-28-0 Boc-Nle-OH 
• 335627-55-9 (4S,5R)-5-benzyloxy-4-butyl-2-oxazolidinone 
• 24424-99-5 di-tert-butyl dicarbonate 
• 327-57-1 L-Norleucine 
• 335628-07-4 (4S,5R)-5-benzyloxy-3-tert-butoxycarbonyl-4-butyl-2-oxazolidinone 
• 104062-69-3 N-Methoxy-N-methyl 2(S)-(tert-butoxycarbonylamino) hexanamide 
• 116640-17-6 tert-butyl [(1S)-1-(hydroxymethyl)pentyl]carbamate 
• 87974-77-4 methyl (2S)-2-tert-butoxycarbonylaminohexanoate 

Downstream Products

• 1026167-17-8 {1-[(3-chloro-phenylamino)-methyl]-pentyl}-carbamic acid tert-butyl ester 
• 186203-16-7 N-(2,3-Dimethylphenyl)-2(S)-(tert-butoxycarbonylamino) hexanamine 
• 1026798-34-4 {1-[(3-trifluoromethoxy-phenylamino)-methyl]-pentyl}-carbamic acid tert-butyl ester 
• 1026927-99-0 [(S)-1-((E)-2-Benzenesulfonyl-vinyl)-pentyl]-carbamic acid tert-butyl ester 
• 600143-16-6 benzyl (E,4S)-4-[(tert-butoxycarbonyl)amino]oct-2-enoate 
• 865537-92-4 2-[(S)-2-(1-Benzyl-propoxycarbonylamino)-1-hydroxy-hexyl]-thiazole-4-carboxylic acid ethyl ester 
• 865537-90-2 2-[(S)-2-(1-Benzyl-2-methyl-propoxycarbonylamino)-1-hydroxy-hexyl]-thiazole-4-carboxylic acid ethyl ester 
• 865537-95-7 2-[(S)-2-(1-Benzyl-3-methyl-butoxycarbonylamino)-1-hydroxy-hexyl]-thiazole-4-carboxylic acid ethyl ester 
• 865537-85-5 2-[(S)-2-((S)-2-Cyclohexyl-1-methyl-ethoxycarbonylamino)-1-hydroxy-hexyl]-thiazole-4-carboxylic acid ethyl ester 
• 865537-89-9 {(S)-1-[Hydroxy-(4-trifluoromethyl-thiazol-2-yl)-methyl]-pentyl}-carbamic acid (S)-2-cyclohexyl-1-methyl-ethyl ester 
• 865537-84-4 2-[(S)-2-((S)-2-Cyclohexyl-1-methyl-ethoxycarbonylamino)-1-hydroxy-hexyl]-4-methyl-thiazole-5-carboxylic acid ethyl ester 
• 1071154-09-0 5(S)-n-Butyl-1-(2,3-dimethylphenyl)-2-piperazinone 

Relevant articles and documents

Novel 2-oxoamide inhibitors of human group IVA phospholipase A2

A novel class of potent human cytosolic phospholipase A2 (GIVA PLA2) inhibitors was developed. These inhibitors were designed to contain the 2-oxoamide functionality and a free carboxyl group. Among the compounds tested, a longchain

Crystal Structures of Staphylococcus aureus Methionine Aminopeptidase Complexed with Keto Heterocycle and Aminoketone Inhibitors Reveal the Formation of a Tetrahedral Intermediate

High-resolution crystal structures of Staphylococcus aureus methionine aminopeptidase I in complex with various keto heterocycles and aminoketones were determined, and the intermolecular ligand interactions with the enzyme are reported. The compounds are effective inhibitors of the S. aureus enzyme because of the formation of an uncleavable tetrahedral intermediate upon binding. The electron densities unequivocally show the enzyme-catalyzed transition-state analogue mimicking that for amide bond hydrolysis of substrates.

AN EFFICIENT METHOD FOR PREPARATION OF OPTICALLY ACTIVE N-PROTECTED α-AMINO ALDEHYDES FROM N-PROTECTED α-AMINO ALCOHOLS

N-Protected α-amino aldehydes of high optical purity were prepared in excellent yields from corresponding α-amino alcohols by 1,1,1-tris(acetoxy)-1,1-dihydro-1,2-benzodioxol-3(H)-one (periodinane) oxidation.

Triazolo-peptidomimetics: novel radiolabeled minigastrin analogs for improved tumor targeting

MG11 is a truncated analog of minigastrin, a peptide with high affinity and specificity toward the cholecystokinin-2 receptor (CCK2R), which is overexpressed by different tumors. Thus, radiolabeled MG11 derivatives have great potential for use in cancer d

1,2,3-Triazoles as amide bond mimics: Triazole scan yields protease-resistant peptidomimetics for tumor targeting

The triazole makes the difference: Replacement of amide bonds in the backbone of peptides by 1,4-disubstituted 1,2,3-triazole isosteres affords peptidomimetics with retained receptor affinity and cell-internalization properties, enhanced proteolytic stability, and improved tumor-targeting capabilities. Copyright